doi: 10.3164/jcbn.11-08 147 MiaoL.St ClairD
If youre a patient and wondering how to start immune therapy, download our IV prep checklist and bring it to your doctor to get started
The risk was driven by the synthetic progestin What Modern Research Shows The French E3N cohort study (80,000+ women) found no increased breast cancer risk with bioidentical estradiol plus micronized progesterone for up to 5 years The "timing hypothesis" shows women starting HRT within 10 years of menopause receive cardiovascular benefit rather than harm The Danish Osteoporosis Prevention Study showed reduced heart failure, MI, and mortality over 16 years of follow-up Major medical organizations NAMS, Endocrine Society, and IMS now endorse HRT for symptomatic women within the appropriate window Risks and Contraindications Hormone therapy is not risk-free, and we believe in complete transparency
Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist widely studied for its receptor specificity
Semaglutide can be particularly effective for younger men whose fat gain stems from lifestyle factors (dining out, alcohol, irregular eating patterns) rather than hormonal decline